Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMERAUDE: Biomarkers for Neonatal Sepsis Diagnosis
NCT03299751Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Nov 2017
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoint: Late-Onset Sepsis diagnosis in NICU newborns confirmed by adjudication committee at 48 hours. Started Nov 2017; status: completed.
Beyond the preview
Go deeper on NCT03299751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03299751.